Insider Selling: NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Major Shareholder Sells 74,852 Shares of Stock
NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) major shareholder Corp Symetryx sold 74,852 shares of the business’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $1.80, for a total transaction of $134,733.60. Following the transaction, the insider now owns 605,149 shares in the company, valued […]